The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis
Abstract
Objective: Modification of antigens represents a trigger for the generation of autoantibodies. In the pathogenesis of rheumatoid arthritis (RA), citrullination of proteins has been shown to be a critical process, and the determination of antibodies against citrullinated antigens has been a diagnostic milestone. We undertook this study to determine whether antibodies to mutated and citrullinated vimentin (MCV) could serve as a diagnostic and prognostic marker for RA. Methods: We identified novel isoforms of human MCV in the synovial fluid of RA patients. The significance of these disease‐related modifications was investigated by the analysis of autoantibody reactivities. In a group of 1,151 RA patients, the diagnostic significance and the prognostic value of an anti‐MCV enzyme‐linked immunosorbent assay (ELISA) were compared with that of an anti–cyclic citrullinated peptide (anti‐CCP) ELISA. Results: In RA, sensitivities of 82% and 72% were calculated for the anti‐MCV and anti‐CCP assays, respectively. The specificity of both assays was comparable (98% and 96%, respectively). In followup analyses of 16 RA patients with moderate disease activity (mean Disease Activity Score in 28 joints [DAS28] of 2.72) and 26 RA patients with active disease (mean DAS28 of 5.07), disease stratification of RA was possible using the anti‐MCV assay (P = 0.0084). A significant correlation of anti‐MCV antibodies with the DAS28 was documented (r = 0.5334, P = 0.0003), in 42 RA patients (n = 427 antibody determinations at different time points). Conclusion: Antigenic properties of vimentin were determined by mutation and citrullination. Anti‐MCV antibodies are a novel diagnostic marker for RA. Furthermore, they may allow monitoring and—if confirmed in even larger series of patients—stratification of disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Revised Criteria for the Classification of Rheumatoid Arthritis
Arnett, F. C. (1990) · Orthopaedic Nursing · doi:10.1097/00006416-199003000-00011 · Cited by 7,723
Prevoo, M. L. L., Van'T Hof, M. A., Kuper, H. H., Van Leeuwen, M. A., Van De Putte, L. B. A., & Van Riel, P. L. C. M. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380107 · Cited by 6,243
Oxidants, antioxidants, and the degenerative diseases of aging.
Ames, B. N., Shigenaga, M. K., & Hagen, T. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.7915 · Cited by 5,958
Vitali, C., Bombardieri, S., Jonsson, R., Moutsopoulos, H. M., Alexander, E. L., Carsons, S. E., Daniels, T. E., Fox, P. C., Fox, R. I., Kassan, S. S., et al. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.6.554 · Cited by 5,299
Oxidative DNA damage: mechanisms, mutation, and disease
Cooke, M. S., Evans, M. D., Dizdaroglu, M., & Lunec, J. (2003) · The FASEB Journal · doi:10.1096/fj.02-0752rev · Cited by 3,245
Radiographic Evaluation of Rheumatoid Arthritis and Related Conditions by Standard Reference Films
Larsen, A., Dale, K., & Eek, M. (1977) · Acta Radiologica. Diagnosis · doi:10.1177/028418517701800415 · Cited by 1,825
Schellekens, G. A., de Jong, B. A., van den Hoogen, F. H., van de Putte, L. B., & van Venrooij, W. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1316 · Cited by 1,450
Lee, D. M., & Weinblatt, M. E. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06075-5 · Cited by 1,247
Hill, J. A., Southwood, S., Sette, A., Jevnikar, A. M., Bell, D. A., & Cairns, E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.538 · Cited by 713
Fratelli, M., Demol, H., Puype, M., Casagrande, S., Eberini, I., Salmona, M., Bonetto, V., Mengozzi, M., Duffieux, F., Miclet, E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052592699 · Cited by 556
Vimentin is secreted by activated macrophages
Mor-Vaknin, N., Punturieri, A., Sitwala, K., & Markovitz, D. M. (2003) · Nature Cell Biology · doi:10.1038/ncb898 · Cited by 522
Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis
van der Helm-van Mil, A. H., Verpoort, K. N., Breedveld, F. C., Toes, R. E., & Huizinga, T. W. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1767 · Cited by 485
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
Vossenaar, E. R., Després, N., Lapointe, E., van der Heijden, A., Lora, M., Senshu, T., van Venrooij, W. J., & Ménard, H. A. (2004) · Arthritis Res Ther · doi:10.1186/ar1149 · Cited by 463
Vossenaar, E. R., Radstake, T. R. D., van der Heijden, A., van Mansum, M. A. M., Dieteren, C., de Rooij, D.-J., Barrera, P., Zendman, A. J. W., & van Venrooij, W. J. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.012211 · Cited by 455
Intermediate filaments mediate cytoskeletal crosstalk
Chang, L., & Goldman, R. D. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1438 · Cited by 386
Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value.
van Boekel, M. A. M., Vossenaar, E. R., van den Hoogen, F. H. J., & VENROOIJ, W. J. V. (2002) · Arthritis Research · doi:10.1186/ar395 · Cited by 359
Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis
Byun, Y., Chen, F., Chang, R., Trivedi, M., Green, K. J., & Cryns, V. L. (2001) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400840 · Cited by 340
Ishigami, A., Ohsawa, T., Hiratsuka, M., Taguchi, H., Kobayashi, S., Saito, Y., Murayama, S., Asaga, H., Toda, T., Kimura, N., et al. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20431 · Cited by 277
The presence of citrullinated proteins is not specific for rheumatoid synovial tissue
Vossenaar, E. R., Smeets, T. J. M., Kraan, M. C., Raats, J. M., Van Venrooij, W. J., & Tak, P. P. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20584 · Cited by 256
Immunologic Mechanisms in the Pathogenesis of Rheumatoid Arthritis
Firestein, G. S. (2005) · JCR: Journal of Clinical Rheumatology · doi:10.1097/01.rhu.0000166673.34461.33 · Cited by 243
Asaga, H., Yamada, M., & Senshu, T. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8148 · Cited by 208
The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis.
Després, N., Boire, G., López-Longo, F. J., & Ménard, H. A. (1994) · PubMed · Cited by 181
Moisan, É., & Girard, D. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0405190 · Cited by 162
Senshu, T., Akiyama, K., Kan, S., Asaga, H., Ishigami, A., & Manabe, M. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12317070 · Cited by 140
Nijenhuis, S., Zendman, A. J. W., Vossenaar, E. R., Pruijn, G. J. M., & vanVenrooij, W. J. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.07.016 · Cited by 110
The Devil in the Details: The Emerging Role of Anticitrulline Autoimmunity in Rheumatoid Arthritis
van Gaalen, F. A., Ioan‐Facsinay, A., Huizinga, T. W. J., & Toes, R. E. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5575 · Cited by 103
Autoimmunity and tumor immunity induced by immune responses to mutations in self
Engelhorn, M. E., Guevara-Patino, J. A., Noffz, G., Hooper, A. T., Lou, O., Gold, J. S., Kappel, B. J., & Houghton, A. N. (2006) · Nature Medicine · doi:10.1038/nm1363 · Cited by 95
Microsatellite Instability and Suppressed DNA Repair Enzyme Expression in Rheumatoid Arthritis
Lee, S.-H., Chang, D. K., Goel, A., Boland, C. R., Bugbee, W. D., Boyle, D. L., & Firestein, G. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.2214 · Cited by 94
The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis.
Dagenais, P. (1995) · PubMed · Cited by 78
Intermediate Filaments Control the Intracellular Distribution of Caspases During Apoptosis
Dinsdale, D. D., Lee, J. C., Dewson, G., Cohen, G. M., & Peter, M. E. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63130-6 · Cited by 64
Yang, X., Wang, J., Liu, C., Grizzle, W. E., Yu, S., Zhang, S., Barnes, S., Koopman, W. J., Mountz, J. D., Kimberly, R. P., et al. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62045-7 · Cited by 60
Cited by
Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes
Nygaard, G., & Firestein, G. S. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0413-5 · Cited by 928
The etiology of rheumatoid arthritis
Scherer, H. U., Häupl, T., & Burmester, G. R. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102400 · Cited by 881
Self-citationInduction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
Harre, U., Georgess, D., Bang, H., Bozec, A., Axmann, R., Ossipova, E., Jakobsson, P.-J., Baum, W., Nimmerjahn, F., Szarka, E., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60975 · Cited by 736
Self-citationWegner, N., Lundberg, K., Kinloch, A., Fisher, B., Malmström, V., Feldmann, M., & Venables, P. J. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00850.x · Cited by 471
Immunity to Citrullinated Proteins in Rheumatoid Arthritis
Klareskog, L., Rönnelid, J., Lundberg, K., Padyukov, L., & Alfredsson, L. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090244 · Cited by 463
Metadata
- Authors
- Bang, H., Egerer, K., Gauliard, A., Lüthke, K., Rudolph, P. E., Fredenhagen, G., Berg, W., Feist, E., & Burmester, G.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2007-07-30
- Volume
- 56
- Issue
- 8
- Pages
- 2503-2511
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2074391349
- Cited by
- 293
- References
- 33
- FWCI
- 14.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.